Webinar
Tackling the reproducibility crisis with standardised human cells
This expert panel discusses how standardising human iPSC-derived cells can address reproducibility challenges in life science research. Hear from leaders in academia and cell programming on the future of reliable human cell models.
This expert panel discusses how standardising human iPSC-derived cells can address reproducibility challenges in life science research. Hear from leaders in academia and cell programming on the future of reliable human cell models.
Join experts in human iPSC-derived cells as they discuss the impact of standardisation on scientific progress.
The absence of standardised reagents creates barriers to reliable experimental comparisons, slowing research, drug development, and translational efforts. Across human cell models, including primary cells, cell lines, and patient-derived iPSC-derived cells, biological variability and reproducibility challenges persist.
In this expert panel, we will explore how standardising human iPSC-derived cells can enhance consistency and reproducibility, ultimately enabling more robust and impactful research.
Key learning objectives
- Explore the challenges posed by variability in human cell models
- Understand why a lack of standardised cell models impacts reproducibility, and how implementing it can improve research across academia and industry
- Gain insights on the standardisation of human iPSC-derived cells from leaders in academic research and drug discovery